These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21082329)

  • 21. A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models.
    Gopalakrishnan B; Aparna V; Jeevan J; Ravi M; Desiraju GR
    J Chem Inf Model; 2005; 45(4):1101-8. PubMed ID: 16045305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans.
    Pochet S; Dugué L; Labesse G; Delepierre M; Munier-Lehmann H
    Chembiochem; 2003 Aug; 4(8):742-7. PubMed ID: 12898625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzymatic and structural analysis of inhibitors designed against Mycobacterium tuberculosis thymidylate kinase. New insights into the phosphoryl transfer mechanism.
    Haouz A; Vanheusden V; Munier-Lehmann H; Froeyen M; Herdewijn P; Van Calenbergh S; Delarue M
    J Biol Chem; 2003 Feb; 278(7):4963-71. PubMed ID: 12454011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-(1-Arylethylpiperidin-4-yl)thymine Analogs as Antimycobacterial TMPK Inhibitors.
    Jian Y; Hulpia F; D P Risseeuw M; Forbes HE; Caljon G; Munier-Lehmann H; I M Boshoff H; Van Calenbergh S
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32560578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Familiar O; Munier-Lehmann H; Negri A; Gago F; Douguet D; Rigouts L; Hernández AI; Camarasa MJ; Pérez-Pérez MJ
    ChemMedChem; 2008 Jul; 3(7):1083-93. PubMed ID: 18418833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacophore optimization and design of competitive inhibitors of thymidine monophosphate kinase through molecular modeling studies.
    Chitre TS; Kathiravan MK; Bothara KG; Bhandari SV; Jalnapurkar RR
    Chem Biol Drug Des; 2011 Nov; 78(5):826-34. PubMed ID: 21801308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge based identification of potent antitubercular compounds using structure based virtual screening and structure interaction fingerprints.
    Kumar A; Chaturvedi V; Bhatnagar S; Sinha S; Siddiqi MI
    J Chem Inf Model; 2009 Jan; 49(1):35-42. PubMed ID: 19063713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endeavors towards transformation of M. tuberculosis thymidylate kinase (MtbTMPK) inhibitors into potential antimycobacterial agents.
    Jian Y; Merceron R; De Munck S; Forbes HE; Hulpia F; Risseeuw MDP; Van Hecke K; Savvides SN; Munier-Lehmann H; Boshoff HIM; Van Calenbergh S
    Eur J Med Chem; 2020 Nov; 206():112659. PubMed ID: 32823003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
    Gasse C; Douguet D; Huteau V; Marchal G; Munier-Lehmann H; Pochet S
    Bioorg Med Chem; 2008 Jun; 16(11):6075-85. PubMed ID: 18467107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenging the Biginelli scaffold to surpass the first line antitubercular drugs:
    El-Shoukrofy MS; Atta A; Fahmy S; Sriram D; Shehat MG; Labouta IM; Mahran MA
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2386668. PubMed ID: 39258667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of mycobacterial Thymidylate kinase inhibitors: a comprehensive pharmacophore, machine learning, molecular docking, and molecular dynamics simulation studies.
    Chikhale RV; Pawar SP; Kolpe MS; Shinde OD; Dahlous KA; Mohammad S; Patil PC; Bhowmick S
    Mol Divers; 2024 Aug; 28(4):1947-1964. PubMed ID: 39152354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel antimycobacterial chemical agents through the in silico multi-conformational structure-based drug screening of a large-scale chemical library.
    Koseki Y; Kinjo T; Kobayashi M; Aoki S
    Eur J Med Chem; 2013 Feb; 60():333-9. PubMed ID: 23314046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational Overview of Mycobacterial Thymidine Monophosphate Kinase.
    Gul S; Khalil R; Zaheer Ul-Haq ; Mubarak MS
    Curr Pharm Des; 2020; 26(15):1676-1681. PubMed ID: 32242781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The crystal structure of Mycobacterium tuberculosis thymidylate kinase in complex with 3'-azidodeoxythymidine monophosphate suggests a mechanism for competitive inhibition.
    Fioravanti E; Adam V; Munier-Lehmann H; Bourgeois D
    Biochemistry; 2005 Jan; 44(1):130-7. PubMed ID: 15628853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-(Piperidin-3-yl)thymine amides as inhibitors of
    Jian Y; Risseeuw MDP; Froeyen M; Song L; Cappoen D; Cos P; Munier-Lehmann H; van Calenbergh S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1730-1739. PubMed ID: 31822127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium tuberculosis thymidylate kinase: structural studies of intermediates along the reaction pathway.
    Fioravanti E; Haouz A; Ursby T; Munier-Lehmann H; Delarue M; Bourgeois D
    J Mol Biol; 2003 Apr; 327(5):1077-92. PubMed ID: 12662932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and inhibitory activity against Mycobacterium tuberculosis thymidine monophosphate kinase of acyclic nucleoside analogues with a distal imidazoquinolinone.
    Familiar O; Munier-Lehmann H; Aínsa JA; Camarasa MJ; Pérez-Pérez MJ
    Eur J Med Chem; 2010 Dec; 45(12):5910-8. PubMed ID: 20951473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure Guided Lead Generation toward Nonchiral M. tuberculosis Thymidylate Kinase Inhibitors.
    Song L; Merceron R; Gracia B; Quintana AL; Risseeuw MDP; Hulpia F; Cos P; Aínsa JA; Munier-Lehmann H; Savvides SN; Van Calenbergh S
    J Med Chem; 2018 Apr; 61(7):2753-2775. PubMed ID: 29510037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of 6-aza-2'-deoxyuridine monophosphate analogs as inhibitors of thymidylate synthases, and as substrates or inhibitors of thymidine monophosphate kinase in Mycobacterium tuberculosis.
    Kögler M; Busson R; De Jonghe S; Rozenski J; Van Belle K; Louat T; Munier-Lehmann H; Herdewijn P
    Chem Biodivers; 2012 Mar; 9(3):536-56. PubMed ID: 22422522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetrahydro-2-furanyl-2,4(1H,3H)-pyrimidinedione derivatives as novel antibacterial compounds against
    Koseki Y; Kanetaka H; Tsunosaki J; Munier-Lehmann H; Aoki S
    Int J Mycobacteriol; 2017; 6(1):61-69. PubMed ID: 28317807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.